Conducted : Actualité Conducted en direct - P2 | Bourse Reflex
Accueil > Tags > Conducted

  • Toutes les actualités en rapport avec « Conducted »

13/10 18:00 Conducted - Quantum Genomics announces 2016 first-half financial results and first nine months business update

29/09 17:45 Conducted - Quantum Genomics reports positive top-line results from Phase IIa trial of QGC001 in hypertension

21/09 14:30 Conducted - ELECTRO POWER SYSTEMS ACCELERATES DEVELOPMENT AND STRENGTHENS ITS MANAGEMENT TEAM TO SUPPORT GROWTH

06/09 19:00 Conducted - METabolic EXplorer confirms the superior nutritional and economic performance of inoLa(TM): 35% greater nutritional value

02/09 19:00 Conducted - H1 2016 results

02/08 08:30 Conducted - GROWTH IN ORDER BACKLOG ACCELERATES ELECTRO POWER SYSTEMS' H1 2016 SALES

30/06 18:00 Conducted - Quantum Genomics Initiates Phase IIa trial for Heart Failure, the second strategic initiative for its BAPAI therapeutic platform

23/06 17:45 Conducted - GENTICEL REPORTS 18 MONTH INTERIM ANALYSIS OF GTL001 PHASE 2 TRIAL IN HPV16/18 INFECTED WOMEN

13/06 18:35 Conducted - GENTICEL ANNOUNCES COMPLETION OF TWO MAJOR MILESTONES IN PREPARATION FOR PHASE 3 PROGRAM OF GTL001

10/05 18:00 Conducted - Year off to a good start: Organic growth of 6.3% (constant currency and structure)

26/04 18:00 Conducted - Regulatory authorisations received in France to begin Phase IIa multicentric European trial for heart failure

15/03 18:00 Conducted - With a net profit of 3.4 million euros in 2015, FUTUREN reaches its target to be profitable and implements a supported growth dynamic

11/02 19:10 Conducted - Compagnie de Financement Foncier - Annual results 2015

03/02 18:30 Conducted - Quantum Genomics Expands U.S. Presence to Advance its Development Programs for Cardiovascular Diseases

25/01 18:00 Conducted - BUSINESS UPDATE - FOURTH QUARTER 2015

05/01 18:00 Conducted - Patient enrolment 100% completed for Phase IIa trial for high blood pressure

24/11 18:00 Conducted - H1 operating income on ordinary activities up 19% - Full-year growth revised upwards

29/10 18:00 Conducted - Genticel Announces First Patient Treated in U.S. Phase 1 Clinical Trial of GTL001, Company's Therapeutic Vaccine Candidate against HPV 16/18 Infections

15/10 19:15 Conducted - 2015 Half-year results - Update on latest developments

28/09 19:15 Conducted - 1st half 2015 : Agreement signed on MPG, and significant advances in 100% bio-based L-Methionine